Skip to main navigation Skip to search Skip to main content

Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study

Britt Falskov, Thomas Steffen Hermann, Jakob Raunsø, Buris Christiansen, Christian Rask-Madsen, Atheline Major-Pedersen, Lars Køber, Christian Torp-Pedersen, Maria Helena Dominguez Vall-Lamora, Britt Falskov

    Research output: Contribution to journalJournal articleResearchpeer-review

    10 Citations (Scopus)

    Abstract

    Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear. We examined if there were differences in endothelial function, insulin stimulated endothelial function, 24 hour ambulatory blood pressure and heart rate during treatment with carvedilol, metoprolol tartrate and metoprolol succinate in patients with HF.
    Original languageEnglish
    JournalCardiovascular Diabetology
    Volume10
    Pages (from-to)91
    ISSN1475-2840
    DOIs
    Publication statusPublished - 2011

    Cite this